Literature DB >> 16814667

Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk.

Michael Joner1, Aloke V Finn, Andrew Farb, Erik K Mont, Frank D Kolodgie, Elena Ladich, Robert Kutys, Kristi Skorija, Herman K Gold, Renu Virmani.   

Abstract

OBJECTIVES: This study examined human drug-eluting stents (DES) to determine the long-term effects of these stents on coronary arterial healing and identified mechanisms underlying late stent thrombosis (LST).
BACKGROUND: Although DES reduce the need for repeat revascularization compared with bare-metal stents (BMS), data suggest the window of thrombotic risk for Cypher (Cordis Corp., Miami Lakes, Florida) and Taxus (Boston Scientific Corp., Natick, Massachusetts) DES extends far beyond that for BMS.
METHODS: From a registry of 40 autopsies of DES (68 stents), 23 DES cases of >30 days duration were compared with 25 matched autopsies of BMS implantation. Late stent thrombosis was defined as an acute thrombus within a stent >30 days old.
RESULTS: Of 23 patients with DES >30 days old, 14 had evidence of LST. Cypher and Taxus DES showed greater delayed healing characterized by persistent fibrin deposition (fibrin score 2.3 +/- 1.1 vs. 0.9 +/- 0.8, p = 0.0001) and poorer endothelialization (55.8 +/- 26.5%) compared with BMS (89.8 +/- 20.9, p = 0.0001). Moreover, DES with LST showed more delayed healing compared with patent DES. In 5 of 14 patients suffering LST, antiplatelet therapy had been withdrawn. Additional procedural and pathologic risk factors for LST were: 1) local hypersensitivity reaction; 2) ostial and/or bifurcation stenting; 3) malapposition/incomplete apposition; 4) restenosis; and 5) strut penetration into a necrotic core.
CONCLUSIONS: The Cypher and Taxus DES result in delayed arterial healing when compared with BMS of similar implant duration. The cause of DES LST is multifactorial with delayed healing in combination with other clinical and procedural risk factors playing a role.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16814667     DOI: 10.1016/j.jacc.2006.03.042

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  496 in total

1.  Smooth muscle cells orchestrate the endothelial cell response to flow and injury.

Authors:  Mercedes Balcells; Jordi Martorell; Carla Olivé; Marina Santacana; Vipul Chitalia; Angelo A Cardoso; Elazer R Edelman
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

2.  Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.

Authors:  Jia-Ning Wang; Ning Shi; Wei-Bing Xie; Xia Guo; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

3.  Comparison of vascular remodeling in patients treated with sirolimus-versus zotarolimus-eluting stent following acute myocardial infarction.

Authors:  Ki-Woon Kang; Young-Guk Ko; Dong-Ho Shin; Jung-Sun Kim; Byeong-Keuk Kim; Donghoon Choi; Yangsoo Jang; Myeong-Ki Hong
Journal:  Clin Cardiol       Date:  2011-12-12       Impact factor: 2.882

4.  One-year clinical follow-up of a registry evaluating a percutaneous revascularisation strategy combining a pre-specified simple selection process with the use of a new thin-strut bare cobalt-chromium stent.

Authors:  P R Stella; G Pavlakis; P Agostoni; H M Nathoe; S Hoseyni Guyomi; B J Hamer; T X Wildbergh; P A Doevendans; E Van Belle
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

5.  Magnetic stents retain nanoparticle-bound antirestenotic drugs transported by lipid microbubbles.

Authors:  T Räthel; H Mannell; J Pircher; B Gleich; U Pohl; F Krötz
Journal:  Pharm Res       Date:  2011-12-22       Impact factor: 4.200

Review 6.  Late stent thrombosis: the last remaining obstacle in coronary interventional therapy.

Authors:  Piera Capranzano; George Dangas
Journal:  Curr Cardiol Rep       Date:  2012-08       Impact factor: 2.931

7.  Recurrent stent fracture in the right coronary artery.

Authors:  Adnan K Chhatriwalla; Samuel Unzek; Samir R Kapadia
Journal:  Clin Cardiol       Date:  2010-11-11       Impact factor: 2.882

8.  Temporal changes of coronary artery plaque located behind the struts of the everolimus eluting bioresorbable vascular scaffold.

Authors:  Salvatore Brugaletta; Hector M Garcia-Garcia; Scot Garg; Josep Gomez-Lara; Roberto Diletti; Yoshinobu Onuma; Robert Jan van Geuns; Dougal McClean; Dariusz Dudek; Leif Thuesen; Bernard Chevalier; Stephan Windecker; Robert Whitbourn; Cecile Dorange; Karine Miquel-Hebert; Krishnankutty Sudhir; John A Ormiston; Patrick W Serruys
Journal:  Int J Cardiovasc Imaging       Date:  2010-10-13       Impact factor: 2.357

9.  Vitamin D attenuates HMGB1-mediated neointimal hyperplasia after percutaneous coronary intervention in swine.

Authors:  Mohan Satish; Palanikumar Gunasekar; Juan A Asensio; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2020-08-01       Impact factor: 3.396

10.  Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.

Authors:  Randolph Hutter; Li Huang; Walter S Speidl; Chiara Giannarelli; Paul Trubin; Gerhard Bauriedel; Mary E Klotman; Valentin Fuster; Juan J Badimon; Paul E Klotman
Journal:  Circulation       Date:  2013-09-16       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.